Everbridge Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Everbridge Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||
net income | -20,068,000 | -19,290,000 | 1,683,000 | -15,050,000 | -14,648,000 | 16,161,000 | -22,080,000 | -36,182,000 | -19,073,000 | -10,508,000 | -28,678,000 | -33,821,000 | -21,789,000 | -24,586,000 | -24,205,000 | -19,220,000 | -25,385,000 | -13,132,000 | -12,921,000 | -12,063,000 | -14,134,000 | -9,805,000 | -8,450,000 | -16,918,000 | -12,342,000 | -5,764,000 | -4,231,000 | -3,437,000 | -6,202,000 | -2,628,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||
depreciation and amortization | 14,447,000 | 14,527,000 | 14,630,000 | 14,884,000 | 14,774,000 | 15,347,000 | 14,562,000 | 15,257,000 | 15,434,000 | 15,088,000 | 14,226,000 | 13,011,000 | 10,843,000 | 8,643,000 | 8,140,000 | 7,320,000 | 6,656,000 | 6,479,000 | 5,492,000 | 3,995,000 | 3,705,000 | 3,521,000 | 3,844,000 | 3,690,000 | 2,638,000 | 2,561,000 | 2,418,000 | 2,295,000 | 2,933,000 | 2,067,000 |
amortization of deferred costs | 4,860,000 | 5,090,000 | 4,986,000 | 4,978,000 | 4,514,000 | 4,886,000 | 4,625,000 | 4,777,000 | 3,963,000 | 3,975,000 | 3,214,000 | 3,462,000 | 3,722,000 | 3,457,000 | 3,417,000 | 2,813,000 | 2,922,000 | 2,496,000 | 1,879,000 | 2,009,000 | 1,598,000 | 1,415,000 | 1,280,000 | 1,233,000 | ||||||
deferred income taxes | -35,000 | -875,000 | -332,000 | -204,000 | -501,000 | 1,949,000 | 436,000 | -1,015,000 | -6,553,000 | -1,740,000 | -1,454,000 | -3,077,000 | -6,701,000 | -1,168,000 | 704,000 | -1,768,000 | -1,246,000 | 42,000 | 41,000 | 24,000 | 0 | 67,000 | 34,000 | -109,000 | 21,000 | 86,000 | ||||
accretion of interest on convertible senior notes | 519,000 | 518,000 | 684,000 | 723,000 | 715,000 | 1,069,000 | 1,168,000 | 1,166,000 | 1,158,000 | 9,801,000 | 5,578,000 | 5,513,000 | 5,436,000 | 1,243,000 | 1,223,000 | 1,201,000 | 1,161,000 | 1,140,000 | 1,134,000 | |||||||||||
(gain) loss on disposal of assets | 1,000 | -356,000 | 0 | |||||||||||||||||||||||||||
benefit from credit losses and sales reserve | 441,000 | -202,000 | -123,000 | 691,000 | 1,635,000 | 1,122,000 | -990,000 | 65,000 | 213,000 | 2,071,000 | 774,000 | 343,000 | 1,562,000 | 1,629,000 | 55,000 | 462,000 | 925,000 | |||||||||||||
stock-based compensation | 11,412,000 | 10,712,000 | 8,598,000 | 16,130,000 | 13,449,000 | 7,918,000 | 17,407,000 | 16,211,000 | 6,084,000 | -1,536,000 | 17,441,000 | 15,505,000 | 12,685,000 | 11,816,000 | 13,351,000 | 11,278,000 | 10,310,000 | 9,395,000 | 8,301,000 | 8,008,000 | 7,785,000 | 5,582,000 | 3,495,000 | 9,926,000 | 6,586,000 | 4,380,000 | 2,794,000 | 1,089,000 | 955,000 | 929,000 |
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||
accounts receivable | 17,853,000 | -26,503,000 | 4,362,000 | 9,083,000 | 11,994,000 | -29,608,000 | 5,729,000 | 11,611,000 | 11,420,000 | -34,207,000 | -3,292,000 | 7,830,000 | 11,482,000 | -14,685,000 | -11,270,000 | 2,896,000 | 445,000 | -17,153,000 | -7,018,000 | -6,930,000 | 5,543,000 | -4,147,000 | -4,103,000 | -3,968,000 | 9,595,000 | -9,476,000 | -618,000 | -7,250,000 | 4,277,000 | -1,904,000 |
prepaid expenses | -1,097,000 | 2,551,000 | -955,000 | 1,853,000 | -2,465,000 | 543,000 | 2,085,000 | 379,000 | -2,447,000 | -571,000 | 1,015,000 | 299,000 | -1,221,000 | 769,000 | -1,487,000 | -208,000 | -3,057,000 | 1,663,000 | -1,683,000 | 772,000 | -4,233,000 | 487,000 | -428,000 | -360,000 | -1,651,000 | 1,001,000 | -508,000 | 27,000 | -1,071,000 | 840,000 |
deferred costs | -4,621,000 | -9,747,000 | -5,567,000 | -7,339,000 | -5,909,000 | -6,906,000 | -5,627,000 | -4,309,000 | -6,221,000 | -5,406,000 | -3,280,000 | -4,657,000 | -3,450,000 | -6,902,000 | -5,057,000 | -2,223,000 | -4,720,000 | -6,855,000 | -4,040,000 | -2,171,000 | -2,227,000 | -1,294,000 | -2,793,000 | -1,975,000 | -2,223,000 | |||||
other assets | 3,000,000 | 3,027,000 | 1,749,000 | -3,232,000 | -597,000 | -11,118,000 | 1,368,000 | 4,404,000 | 1,819,000 | 5,353,000 | -5,675,000 | 1,918,000 | -2,768,000 | 3,394,000 | 181,000 | 640,000 | -4,069,000 | 834,000 | 841,000 | -2,070,000 | 2,153,000 | -2,430,000 | -579,000 | 1,013,000 | -2,018,000 | 195,000 | -1,009,000 | -309,000 | 338,000 | 647,000 |
accounts payable | -6,539,000 | 2,251,000 | 2,870,000 | 798,000 | -1,732,000 | -1,683,000 | 1,015,000 | 1,937,000 | -6,124,000 | 7,307,000 | -3,475,000 | 851,000 | -911,000 | -739,000 | 122,000 | 3,236,000 | -1,072,000 | -2,006,000 | 3,649,000 | -443,000 | 4,112,000 | -1,150,000 | -206,000 | -609,000 | 702,000 | -910,000 | 1,250,000 | -426,000 | -4,000 | -674,000 |
accrued payroll and employee related liabilities | -1,837,000 | 7,752,000 | 90,000 | -4,541,000 | -1,652,000 | 2,783,000 | 1,052,000 | -6,109,000 | -1,862,000 | 6,499,000 | 1,508,000 | -3,190,000 | -2,130,000 | -466,000 | 4,299,000 | -3,555,000 | 3,221,000 | 2,574,000 | 4,838,000 | -4,069,000 | 1,205,000 | 2,577,000 | 1,804,000 | -4,097,000 | 4,402,000 | 1,333,000 | 1,763,000 | -388,000 | 888,000 | -246,000 |
accrued expenses | -18,343,000 | 19,602,000 | 6,651,000 | -3,715,000 | -797,000 | 1,629,000 | -2,474,000 | -1,409,000 | 3,246,000 | 252,000 | 1,865,000 | -2,041,000 | 3,012,000 | 1,058,000 | 592,000 | -2,325,000 | 1,732,000 | -1,012,000 | 423,000 | 346,000 | -1,065,000 | 919,000 | -1,187,000 | -818,000 | 1,384,000 | -78,000 | -347,000 | 199,000 | 94,000 | 234,000 |
deferred revenue | 4,316,000 | 18,763,000 | -6,712,000 | -8,762,000 | 3,589,000 | 13,424,000 | -152,000 | -12,562,000 | 8,036,000 | 22,851,000 | 3,924,000 | -8,553,000 | 8,373,000 | 23,857,000 | 3,829,000 | -7,840,000 | 5,118,000 | 17,331,000 | 10,850,000 | -1,244,000 | 2,767,000 | 5,927,000 | 6,176,000 | 3,133,000 | -2,072,000 | 8,577,000 | 4,933,000 | 3,684,000 | -816,000 | 3,377,000 |
other liabilities | -2,167,000 | 1,801,000 | -2,947,000 | -927,000 | -1,442,000 | 11,064,000 | -4,865,000 | -5,074,000 | -1,339,000 | 1,424,000 | -798,000 | -2,677,000 | -1,955,000 | 4,962,000 | -239,000 | -889,000 | 3,585,000 | -1,985,000 | 121,000 | 234,000 | 277,000 | 1,231,000 | 445,000 | -361,000 | 373,000 | -618,000 | 104,000 | 376,000 | -13,000 | -52,000 |
net cash from operating activities | 2,142,000 | 29,621,000 | 17,009,000 | 5,370,000 | 20,575,000 | 4,354,000 | 18,035,000 | -9,924,000 | 7,702,000 | 10,212,000 | -2,690,000 | -5,137,000 | 19,808,000 | 19,399,000 | -527,000 | -3,870,000 | 801,000 | 1,463,000 | 12,343,000 | -12,176,000 | 8,687,000 | 4,071,000 | 676,000 | -8,960,000 | 7,508,000 | 484,000 | 6,738,000 | -3,818,000 | 1,459,000 | 2,968,000 |
cash flows from investing activities: | ||||||||||||||||||||||||||||||
capital expenditures | -247,000 | -1,093,000 | -1,945,000 | -1,604,000 | -575,000 | -511,000 | -225,000 | -879,000 | -1,847,000 | -885,000 | -2,042,000 | -316,000 | -1,812,000 | -1,135,000 | -947,000 | -651,000 | -524,000 | -852,000 | -542,000 | -1,102,000 | -2,773,000 | -866,000 | -441,000 | -161,000 | -253,000 | -330,000 | -832,000 | -282,000 | -223,000 | -231,000 |
free cash flows | 1,895,000 | 28,528,000 | 15,064,000 | 3,766,000 | 20,000,000 | 3,843,000 | 17,810,000 | -10,803,000 | 5,855,000 | 9,327,000 | -4,732,000 | -5,453,000 | 17,996,000 | 18,264,000 | -1,474,000 | -4,521,000 | 277,000 | 611,000 | 11,801,000 | -13,278,000 | 5,914,000 | 3,205,000 | 235,000 | -9,121,000 | 7,255,000 | 154,000 | 5,906,000 | -4,100,000 | 1,236,000 | 2,737,000 |
proceeds from landlord reimbursement | 2,006,000 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
proceeds from sale of assets | 13,000 | 0 | 0 | 79,000 | 4,289,000 | |||||||||||||||||||||||||
additions to capitalized software development costs | -3,958,000 | -3,836,000 | -4,835,000 | -3,757,000 | -4,112,000 | -3,456,000 | -4,173,000 | -3,106,000 | -4,330,000 | -5,818,000 | -2,797,000 | -3,587,000 | -2,495,000 | -2,355,000 | -2,623,000 | -2,669,000 | -2,004,000 | -1,952,000 | -1,918,000 | -1,931,000 | -2,018,000 | -1,777,000 | -2,684,000 | -2,039,000 | -1,999,000 | -1,574,000 | -1,542,000 | -1,557,000 | -1,487,000 | -1,200,000 |
net cash from investing activities | -2,186,000 | -4,929,000 | -6,692,000 | -5,282,000 | -398,000 | -4,303,000 | -4,381,000 | -3,985,000 | -6,224,000 | -69,108,000 | -6,852,000 | -169,168,000 | -36,708,000 | -21,010,000 | -14,062,000 | -12,644,000 | -37,469,000 | -2,804,000 | -50,615,000 | 10,861,000 | 17,984,000 | -21,155,000 | -26,494,000 | 7,364,000 | -8,128,000 | -20,653,000 | -13,503,000 | -14,165,000 | -22,945,000 | -3,987,000 |
cash flows from financing activities: | ||||||||||||||||||||||||||||||
payments associated with shares withheld to settle employee tax withholding liability | -2,164,000 | -1,667,000 | -2,529,000 | -1,823,000 | -1,866,000 | |||||||||||||||||||||||||
proceeds from employee stock purchase plan | 1,853,000 | 0 | 1,745,000 | 0 | 2,546,000 | 0 | 1,463,000 | 0 | 1,702,000 | 0 | 2,136,000 | 0 | 2,451,000 | 0 | 1,679,000 | 0 | 1,710,000 | 0 | 1,054,000 | 0 | 1,283,000 | 65,000 | 877,000 | 0 | 881,000 | 0 | 686,000 | 0 | 854,000 | |
proceeds from stock option exercises | 53,000 | 25,000 | 12,000 | 1,263,000 | 17,000 | 65,000 | 17,000 | 784,000 | 559,000 | 1,604,000 | 2,179,000 | 1,596,000 | 2,989,000 | 2,335,000 | 4,741,000 | 8,746,000 | 2,986,000 | 4,369,000 | 1,466,000 | |||||||||||
other | -18,000 | -20,000 | -19,000 | -19,000 | -19,000 | -19,000 | -17,000 | -19,000 | -19,000 | 0 | 400,000 | -531,000 | 0 | |||||||||||||||||
net cash from financing activities | -276,000 | -1,635,000 | -130,357,000 | -1,830,000 | 1,924,000 | -289,521,000 | -450,000 | -1,678,000 | 1,129,000 | -3,520,000 | -3,425,000 | -1,503,000 | 284,792,000 | -699,000 | 516,000 | 1,069,000 | 4,168,000 | 341,911,000 | -693,000 | 4,245,000 | 148,638,000 | 1,076,000 | -406,000 | 1,188,000 | 1,241,000 | 99,066,000 | -2,275,000 | 11,116,000 | 568,000 | -586,000 |
effect of exchange rates on cash, cash equivalents and restricted cash | -732,000 | 1,767,000 | -1,295,000 | -134,000 | 63,000 | 1,391,000 | -1,010,000 | -1,943,000 | -356,000 | 208,000 | -369,000 | 903,000 | -315,000 | 707,000 | 8,000 | 247,000 | -666,000 | -23,000 | -175,000 | -24,000 | -28,000 | |||||||||
net increase in cash, cash equivalents and restricted cash | -1,052,000 | -1,876,000 | 22,164,000 | -288,079,000 | 12,194,000 | -17,530,000 | 2,251,000 | -62,208,000 | -13,336,000 | -174,905,000 | 267,577,000 | -1,603,000 | -14,065,000 | -15,198,000 | -33,166,000 | 340,547,000 | -39,140,000 | 2,906,000 | 175,281,000 | 582,000 | ||||||||||
cash, cash equivalents and restricted cash—beginning of period | 125,371,000 | 0 | 0 | 201,594,000 | 0 | 0 | 492,758,000 | 0 | 0 | 475,630,000 | 0 | 0 | 539,662,000 | 0 | 0 | 60,068,000 | 0 | 0 | 103,051,000 | |||||||||||
cash, cash equivalents and restricted cash—end of period | 124,319,000 | -121,335,000 | -1,876,000 | 223,758,000 | 12,194,000 | -17,530,000 | 495,009,000 | -13,336,000 | -174,905,000 | 743,207,000 | -14,065,000 | -15,198,000 | 506,496,000 | -39,140,000 | 2,906,000 | 235,349,000 | -26,305,000 | -1,034,000 | 103,633,000 | |||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||||||||||||||
cash paid during the period for: | ||||||||||||||||||||||||||||||
interest | 40,000 | 1,052,000 | 275,000 | 0 | 284,000 | 0 | 292,000 | 318,000 | 964,000 | 0 | 903,000 | 0 | 863,000 | 0 | 7,000 | |||||||||||||||
taxes, net of refunds received | 589,000 | 942,000 | 1,579,000 | 2,750,000 | 617,000 | 171,000 | 366,000 | 844,000 | 335,000 | -21,000 | 629,000 | 261,000 | 674,000 | 129,000 | 101,000 | 292,000 | 184,000 | 2,000 | 39,000 | 2,000 | 22,000 | 6,000 | -3,000 | |||||||
supplemental disclosure of non-cash activities: | ||||||||||||||||||||||||||||||
capitalized assets included in accounts payable and accrued expenses | 120,000 | -586,000 | -24,000 | 151,000 | 660,000 | 1,195,000 | 205,000 | -287,000 | 147,000 | 226,000 | 14,000 | -95,000 | -472,000 | 689,000 | 1,331,000 | 193,000 | 47,000 | 38,000 | 49,000 | -1,311,000 | 1,140,000 | 195,000 | -28,000 | |||||||
stock-based compensation capitalized for software development | 799,000 | 1,402,000 | 737,000 | 1,267,000 | 376,000 | 94,000 | 58,000 | 80,000 | 82,000 | 274,000 | 64,000 | -14,000 | 46,000 | 96,000 | 108,000 | 47,000 | 9,000 | 12,000 | 13,000 | 7,000 | ||||||||||
gain on extinguishment of debt, capped call modification and change in fair value | ||||||||||||||||||||||||||||||
change in fair value of contingent consideration obligation | 0 | 0 | 2,165,000 | |||||||||||||||||||||||||||
payment of contingent consideration in excess of acquisition date fair value | 0 | |||||||||||||||||||||||||||||
other non-cash adjustments | -352,000 | -5,000 | -52,000 | -335,000 | 45,000 | 115,000 | -147,000 | 115,000 | -85,000 | |||||||||||||||||||||
change in operating assets and liabilities: | ||||||||||||||||||||||||||||||
payments for acquisition of business, net of acquired cash | -62,405,000 | -2,013,000 | -165,265,000 | -32,401,000 | -381,000 | -10,492,000 | -9,324,000 | -34,941,000 | 0 | -51,655,000 | 0 | 0 | 0 | 0 | 0 | -21,235,000 | ||||||||||||||
proceeds from issuance of convertible notes | 0 | 0 | 0 | 375,000,000 | ||||||||||||||||||||||||||
payments of debt issuance costs | 0 | -249,000 | -829,000 | -9,562,000 | 0 | 0 | 0 | -84,000 | -3,794,000 | |||||||||||||||||||||
purchase of convertible notes capped call hedge | 0 | 0 | 0 | -35,100,000 | ||||||||||||||||||||||||||
repurchase of convertible notes | 0 | -2,000 | 0 | 0 | -58,641,000 | |||||||||||||||||||||||||
proceeds from termination of convertible notes capped call hedge | 0 | 0 | 0 | 10,650,000 | ||||||||||||||||||||||||||
payments of contingent consideration obligation | ||||||||||||||||||||||||||||||
proceeds from option exercises | 782,000 | 972,000 | 1,103,000 | 12,000 | 2,000 | |||||||||||||||||||||||||
cash, cash equivalents and restricted cash—beginning of year | ||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash—end of year | ||||||||||||||||||||||||||||||
cash paid during the year for: | ||||||||||||||||||||||||||||||
supplemental disclosure of non-cash activities | ||||||||||||||||||||||||||||||
common stock issued in connection with acquisitions | 80,254,000 | 1,773,000 | 64,482,000 | 23,032,000 | 0 | 17,685,000 | 5,074,000 | 30,434,000 | ||||||||||||||||||||||
contingent consideration in connection with acquisitions | 60,000 | 0 | 0 | 9,135,000 | 0 | 2,047,000 | 1,690,000 | 2,530,000 | ||||||||||||||||||||||
common stock issued in connection with contingent consideration payment | 0 | |||||||||||||||||||||||||||||
purchase accounting payable | -634,000 | 155,000 | 464,000 | |||||||||||||||||||||||||||
common stock issued in connection with settlement of convertible notes | 283,000 | 0 | 1,176,000 | 15,650,000 | 10,437,000 | |||||||||||||||||||||||||
modification of 2022 notes capped call options and resulting reclassification from equity to derivative asset | 0 | |||||||||||||||||||||||||||||
common stock received in connection with settlement of capped call options | ||||||||||||||||||||||||||||||
purchased intangible asset decrease | ||||||||||||||||||||||||||||||
capitalized development costs included in accounts payable and accrued expenses | 105,000 | -10,000 | 13,000 | 64,000 | -7,000 | -2,000 | 16,000 | |||||||||||||||||||||||
treasury stock retired | ||||||||||||||||||||||||||||||
other non-cash activities | -199,000 | 145,000 | 120,000 | 100,000 | ||||||||||||||||||||||||||
(gain) loss on extinguishment of convertible notes, capped call modification and change in fair value | ||||||||||||||||||||||||||||||
payment for acquisition of business, net of acquired cash | -1,202,000 | 0 | -47,000 | |||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -26,305,000 | |||||||||||||||||||||||||||||
(gain) loss on extinguishment of debt, capped call modification and change in fair value | ||||||||||||||||||||||||||||||
purchase of intangibles | ||||||||||||||||||||||||||||||
deferred consideration in connection with acquisition | ||||||||||||||||||||||||||||||
loss on disposal of assets | 0 | 28,000 | 0 | 84,000 | 0 | 0 | ||||||||||||||||||||||||
loss on extinguishment of convertible notes, capped call modification and change in fair value | ||||||||||||||||||||||||||||||
payment of contingent consideration | 0 | |||||||||||||||||||||||||||||
stock award shares withheld to settle employee tax withholding liability | -1,913,000 | -1,724,000 | -571,000 | |||||||||||||||||||||||||||
common stock issued in connection with acquisition | -40,000 | |||||||||||||||||||||||||||||
contingent consideration in connection with acquisition | ||||||||||||||||||||||||||||||
stock-based compensation capitalized for software development costs | 810,000 | 635,000 | 230,000 | 191,000 | 130,000 | 85,000 | ||||||||||||||||||||||||
loss on extinguishment of convertible notes and capped call modification | 0 | 37,000 | 2,888,000 | |||||||||||||||||||||||||||
debt issuance costs included in accrued expenses | -828,000 | 1,078,000 | ||||||||||||||||||||||||||||
(gain) loss on extinguishment of debt and capped call modification | ||||||||||||||||||||||||||||||
purchase of short-term investments | 0 | 0 | 0 | -1,975,000 | -29,495,000 | -26,777,000 | 0 | -30,932,000 | -30,809,000 | -17,528,000 | ||||||||||||||||||||
maturities of short-term investments | 0 | 3,500,000 | 19,515,000 | 24,750,000 | 11,000,000 | 3,424,000 | 45,145,000 | 25,500,000 | 12,060,000 | |||||||||||||||||||||
proceeds from public offering, net of costs | 0 | 0 | -5,000 | 139,115,000 | ||||||||||||||||||||||||||
shares withheld to settle employee tax withholding liability | ||||||||||||||||||||||||||||||
restricted stock units withheld to settle employee tax withholding liability | -3,556,000 | -1,233,000 | -1,610,000 | -2,095,000 | -3,342,000 | -71,000 | -4,082,000 | -116,000 | -333,000 | -4,000 | -4,149,000 | -2,750,000 | -1,022,000 | |||||||||||||||||
accretion of interest on debt | 9,508,000 | 6,313,000 | ||||||||||||||||||||||||||||
common stock issued in connection with contingent consideration | ||||||||||||||||||||||||||||||
loss on extinguishment of convertible notes | ||||||||||||||||||||||||||||||
acquisition-related deferred consideration | ||||||||||||||||||||||||||||||
acquisition-related deferred common stock consideration | ||||||||||||||||||||||||||||||
benefit from doubtful accounts and sales return reserve | ||||||||||||||||||||||||||||||
proceeds from sale leaseback transaction | 0 | 399,000 | ||||||||||||||||||||||||||||
debt issuance costs included in accounts payable and other assets | ||||||||||||||||||||||||||||||
deferred offering costs in accounts payable and accrued expenses | -322,000 | 465,000 | -587,000 | |||||||||||||||||||||||||||
note payable issued for asset acquisition | 0 | |||||||||||||||||||||||||||||
note payable issued for business acquisition | ||||||||||||||||||||||||||||||
benefit from doubtful accounts and sales reserve | 253,000 | 241,000 | 148,000 | 134,000 | 216,000 | -192,000 | 219,000 | 289,000 | 80,000 | |||||||||||||||||||||
additions to intangibles | -16,000 | -32,000 | -136,000 | |||||||||||||||||||||||||||
non-cash investment income | -56,000 | -189,000 | -190,000 | -80,000 | -69,000 | -159,000 | -130,000 | -66,000 | ||||||||||||||||||||||
change in fair value of contingent consideration | 0 | |||||||||||||||||||||||||||||
payment on note payable | ||||||||||||||||||||||||||||||
payments on finance lease obligation | ||||||||||||||||||||||||||||||
purchase of cost investment | -308,000 | |||||||||||||||||||||||||||||
payments on note payable | -52,000 | |||||||||||||||||||||||||||||
payments on finance lease obligations | -121,000 | |||||||||||||||||||||||||||||
amortization of deferred commissions | ||||||||||||||||||||||||||||||
non-cash interest expense on line of credit and term loan | 0 | |||||||||||||||||||||||||||||
increase in operating assets and liabilities: | ||||||||||||||||||||||||||||||
proceeds from line of credit | 0 | |||||||||||||||||||||||||||||
payments on line of credit | 0 | |||||||||||||||||||||||||||||
payments of issuance costs relating to line of credit and term loan | 0 | |||||||||||||||||||||||||||||
principal payments on capital leases | -38,000 | 0 | ||||||||||||||||||||||||||||
proceeds from public offering, net of underwriters discounts and commissions | ||||||||||||||||||||||||||||||
payments of public offering costs | 0 | -143,000 | -431,000 | -298,000 | ||||||||||||||||||||||||||
payments on notes payable | 0 | |||||||||||||||||||||||||||||
(payments) proceeds from term loan | 0 | |||||||||||||||||||||||||||||
purchase of convertible note capped call hedge | ||||||||||||||||||||||||||||||
proceeds from warrant exercises | 0 | |||||||||||||||||||||||||||||
repurchase of common stock | ||||||||||||||||||||||||||||||
effect of exchange rates on cash and cash equivalents | -218,000 | -81,000 | -626,000 | -39,000 | 229,000 | -165,000 | 21,000 | -168,000 | 74,000 | |||||||||||||||||||||
net increase in cash and cash equivalents | 79,126,000 | -1,531,000 | ||||||||||||||||||||||||||||
taxes, net of | ||||||||||||||||||||||||||||||
debt issuance costs included in accounts payable and accrued expenses | -16,000 | |||||||||||||||||||||||||||||
proceeds from sale leaseback | ||||||||||||||||||||||||||||||
proceeds from follow on offering | ||||||||||||||||||||||||||||||
change in restricted cash | 0 | 0 | ||||||||||||||||||||||||||||
cash and cash equivalents—beginning of year | 60,765,000 | |||||||||||||||||||||||||||||
cash and cash equivalents—end of year | 39,679,000 | |||||||||||||||||||||||||||||
payment on term loan | ||||||||||||||||||||||||||||||
payments of issuance costs relating to the line of credit and term loan | ||||||||||||||||||||||||||||||
proceeds from public offering, net of underwriters discount and commissions | ||||||||||||||||||||||||||||||
proceeds from exercise of warrants | ||||||||||||||||||||||||||||||
cash and cash equivalents—beginning of period | 0 | |||||||||||||||||||||||||||||
cash and cash equivalents—end of period | -9,205,000 | |||||||||||||||||||||||||||||
proceeds from follow-on offering, net of underwriters discount and commissions | ||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -6,846,000 | -21,086,000 | ||||||||||||||||||||||||||||
accretion of interest on notes payable | ||||||||||||||||||||||||||||||
benefit from doubtful accounts | 292,000 | |||||||||||||||||||||||||||||
proceeds from initial public offering, net of underwriters discounts and commissions | 0 | |||||||||||||||||||||||||||||
payments of initial public offering costs | -588,000 | |||||||||||||||||||||||||||||
issuance of common stock in connection with acquisition | ||||||||||||||||||||||||||||||
issuance of notes payable in connection with acquisition | ||||||||||||||||||||||||||||||
cash—beginning of year | ||||||||||||||||||||||||||||||
cash—end of year | ||||||||||||||||||||||||||||||
taxes |
We provide you with 20 years of cash flow statements for Everbridge stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Everbridge stock. Explore the full financial landscape of Everbridge stock with our expertly curated income statements.
The information provided in this report about Everbridge stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.